Replies to post #246998 on Biotech Values

[shareholder_boar]

AMGN also says there will be no bundling of HZNP's products:

Yeah, I'm surprised the parties could not work that out in a consent decree. But if any buyer would face deal scrutiny over anticompetitive bundling and not product overlap, it would be AMGN:

https://www.fiercepharma.com/pharma/regenerons-cholesterol-drug-war-heats-antitrust-lawsuit-over-amgens-bundling-scheme

Attempts by AMGN to have that case dismissed were recently denied.